GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis

Genes and Immunity

Volumn 17, Issue 5, 2016, Pages 305-312

  Hussman, J P ^a   Beecham, A H ^b   Schmidt, M ^b   Martin, E R ^b   McCauley, J L ^b   Vance, J M ^b   Haines, J L ^c   Pericak Vance, M A ^b  

^a Hussman Foundation   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; STROMAL INTERACTION MOLECULE 2; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SOX8;

ARTICLE; BATF GENE; CADM1 GENE; CELL LINEAGE; CONTROLLED STUDY; CSF2RB GENE; DAP GENE; DPP4 GENE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INFLAMMATORY CELL; INPP5D GENE; KAT5 GENE; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALT1 GENE; MAP3K14 GENE; MERTK GENE; MULTIPLE SCLEROSIS; NCOA2 GENE; NFKBIZ GENE; PRIORITY JOURNAL; RGCC GENE; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TNFAIP8 GENE; TXK GENE; UBASH3B GENE; ZNF746 GENE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; GENE LOCUS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION;

CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84973325720     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2016.23     Document Type: Article

References (82)

1. De Luca J, Nocentini U. Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis. Neuro Rehabilitation 2011; 29: 197-219.
2. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996; 13: 464-476.
3. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991; 38: 1-15.
4. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006; 15: 2813-2824.
5. Patsopoulos NA, the Bayer Pharma MS Genetics Working Group, the Steering Committees of Studies Evaluating IFNbeta-1b and a CCR1-Antagonist, ANZgene Consortium, Gene MSA, International Multiple Sclerosis Genetics Consortium et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897-912.
6. International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.
7. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39: 1083-1091.
8. International Multiple Sclerosis Genetics Consortium (IMSGC). Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet 2010; 19: 953-962.
9. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009; 41: 776-782.
10. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
11. International Multiple Sclerosis Genetics Consortium, Lill CM, Schjeide BM, Graetz C, Ban M, Alcina A et al. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain 2013; 136: 1778-1782.
12. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A et al. Analysis of immunerelated loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353-1360.
13. Damotte V, Guillot-Noel L, Patsopoulos NA, Madireddy L, El Behi M, International Multiple Sclerosis Genetics Consortium et al. A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility. Genes Immun 2014; 15: 126-132.
14. International Multiple Sclerosis Genetics Consortium. Network-based multiple sclerosis pathway analysis with GWAS data from 15, 000 cases and 30,000 controls. Am J Hum Genet 2013; 92: 854-865.
15. Hussman JP, Chung RH, Griswold AJ, Jaworkski JM, Salyakina D, Ma D et al. A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Mol Autism 2011; 2: 1.
16. de Castro RO, Zhang J, Groves JR, Barbu EA, Siraganian RP. Once phosphorylated, tyrosines in carboxyl terminus of protein-tyrosine kinase Syk interact with signaling proteins, including TULA-2, a negative regulator of mast cell degranulation. J Biol Chem 2012; 287: 8194-8204.
17. Nojek IM, Werbajh SE, Colo GP, Rubio FM, Franco LD, Nahmod VE et al. Different enzymatic activities recruitment by specific domains of TIF2 are involved in NF-kappaB transactivation. Medicina (B Aires) 2004; 64: 135-138.
18. Sun SC, Chang JH, Jin J. Regulation of nuclear factor-kappaB in autoimmunity. Trends Immunol 2013; 34: 282-289.
19. Kim SY, Baik KH, Baek KH, Chah KH, Kim KA, Moon G et al. S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway. Mol Cell Biol 2014; 34: 510-521.
20. Ebner K, Bandion A, Binder BR, de Martin R, Schmid JA. GMCSF activates NF-kappaB via direct interaction of the GMCSF receptor with IkappaB kinase beta. Blood 2003; 102: 192-199.
21. Ma J, McCarl CA, Khalil S, Luthy K, Feske S. T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells. Eur J Immunol 2010; 40: 3028-3042.
22. Takeba Y, Nagafuchi H, Takeno M, Kashiwakura J, Suzuki N. Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription. J Immunol 2002; 168: 2365-2370.
23. Bengsch B, Seigel B, Flecken T, Wolanski J, Blum HE, Thimme R. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). J Immunol 2012; 188: 5438-5447.
24. Boles KS, Barchet W, Diacovo T, Cella M, Colonna M. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood 2005; 106: 779-786.
25. Feinstein E, Druck T, Kastury K, Berissi H, Goodart SA, Overhauser J et al. Assignment of DAP1 and DAPK-genes that positively mediate programmed cell death triggered by IFN-gamma-to chromosome regions 5p12.2 and 9q34.1, respectively. Genomics 1995; 29: 305-307.
26. Tegla CA, Cudrici CD, Azimzadeh P, Singh AK, Trippe R 3rd, Khan A et al. Dual role of Response gene to complement-32 in multiple sclerosis. Exp Mol Pathol 2013; 94: 17-28.
27. Okamoto K, Iwai Y, Oh-Hora M, Yamamoto M, Morio T, Aoki K et al. Ikappa Bzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature 2010; 464: 1381-1385.
28. Disanto G, Kjetil Sandve G, Ricigliano VA, Pakpoor J, Berlanga-Taylor AJ, Handel AE et al. DNase hypersensitive sites and association with multiple sclerosis. Hum Mol Genet 2014; 23: 942-948.
29. Conde C, Rambout X, Lebrun M, Lecat A, Di Valentin E, Dequiedt F et al. The inositol phosphatase SHIP-1 inhibits NOD2-induced NF-kappaB activation by disturbing the interaction of XIAP with RIP2. PLoS One 2012; 7: e41005.
30. Mahurkar S, Moldovan M, Suppiah V, O'Doherty C. Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatment. PLoS One 2013; 8: e57655.
31. Hadidi S, Antignano F, Hughes MR, Wang SK, Snyder K, Sammis GM et al. Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection. Mucosal Immunol 2012; 5: 535-543.
32. Zemans RL, Arndt PG. Tec kinases regulate actin assembly and cytokine expression in LPS-stimulated human neutrophils via JNK activation. Cell Immunol 2009; 258: 90-97.
33. Lee YJ, Han JY, Byun J, Park HJ, Park EM, Chong YH et al. Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-kappaB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury. J Leukoc Biol 2012; 91: 921-932.
34. Ma GZ, Stankovich JAustralia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Kilpatrick TJ, Binder MD, Field J. Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility. PLoS One 2011; 6: e16964.
35. Brustle A, Brenner D, Knobbe CB, Lang PA, Virtanen C, Hershenfield BM et al. The NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cells. J Clin Invest 2012; 122: 4698-4709.
36. Varade J, Comabella M, Ortiz MA, Arroyo R, Fernandez O, Pinto-Medel MJ et al. Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes. Mult Scler 2012; 18: 959-965.
37. Jordan-Williams KL, Poston S, Taparowsky EJ. BATF regulates the development and function of IL-17 producing iNKT cells. BMC Immunol 2013; 14: 16.
38. Akkad DA, Bellenberg B, Esser S, Weiler F, Epplen JT, Gold R et al. Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability. Neurogenetics 2015; 16: 161-168.
39. O'Donnell M, Hong CS, Huang X, Delnicki RJ, Saint-Jeannet JP. Functional analysis of Sox8 during neural crest development in Xenopus. Development 2006; 133: 3817-3826.
40. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O et al. Paris (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 2011; 144: 689-702.
41. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
42. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
43. Housley W, Fernandez S, Vera K, Murikinati S, Grutzendler J, Cuerdon N et al. Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuli. Sci Transl Med 2015; 7: 291ra93.
44. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009; 18: 2078-2090.
45. Hayden MS, Ghosh S. Regulation of NF-kappaB by TNF family cytokines. Semin Immunol 2014; 26: 253-266.
46. Ruan Q, Chen YH. Nuclear factor-kappaB in immunity and inflammation: the Treg and Th17 connection. Adv Exp Med Biol 2012; 946: 207-221.
47. Cheung TC, Steinberg MW, Oborne LM, Macauley MG, Fukuyama S, Sanjo H et al. Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc Natl Acad Sci USA 2009; 106: 6244-6249.
48. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokineinducible enhancers. FASEB J 1995; 9: 899-909.
49. Nomura T, Abe Y, Kamada H, Shibata H, Kayamuro H, Inoue M et al. Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice. J Control Release 2011; 149: 8-14.
50. Bachetti T, Chiesa S, Castagnola P, Bani D, Di Zanni E, Omenetti A et al. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS). Ann Rheum Dis 2013; 72: 1044-1052.
51. Young AM, Campbell EC, Lynch S, Dunn MH, Powis SJ, Suckling J. Regional susceptibility to TNF-alpha induction of murine brain inflammation via classical IKK/NF-kappaB signalling. PLoS One 2012; 7: e39049.
52. Gu L, Ning H, Qian X, Huang Q, Hou R, Almourani R et al. Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation. J Immunol 2013; 191: 3922-3930.
53. Schmitz ML, Krappmann D. Controlling NF-kappaB activation in T cells by costimulatory receptors. Cell Death Differ 2006; 13: 834-842.
54. Hofmann J, Mair F, Greter M, Schmidt-Supprian M, Becher B. NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses. J Exp Med 2011; 208: 1917-1929.
55. Jin W, Zhou XF, Yu J, Cheng X, Sun SC. Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK. Blood 2009; 113: 6603-6610.
56. Yang Y, Xu J, Niu Y, Bromberg JS, Ding Y. T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. J Immunol 2008; 181: 8700-8710.
57. Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H. SOCS, inflammation, and autoimmunity. Front Immunol 2012; 3: 20.
58. Brasier AR. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 2010; 86: 211-218.
59. Shalev I, Schmelzle M, Robson SC, Levy G. Making sense of regulatory T cell suppressive function. Semin Immunol 2011; 23: 282-292.
60. Waldmann TA, Dubois S, Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001; 14: 105-110.
61. Heninger AK, Theil A, Wilhelm C, Petzold C, Huebel N, Kretschmer K et al. IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells. J Immunol 2012; 189: 5649-5658.
62. van Doorn R, Lopes Pinheiro MA, Kooij G, Lakeman K, van het Hof B, van der Pol SM et al. Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. J Neuroinflammation 2012; 9: 133-2094-9-133.
63. Luissint AC, Lutz PG, Calderwood DA, Couraud PO, Bourdoulous S. JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4-beta1 integrin activation. J Cell Biol 2008; 183: 1159-1173.
64. Ferreira TB, Hygino J, Barros PO, Teixeira B, Kasahara TM, Linhares UC et al. Endogenous interleukin-6 amplifies interleukin-17 production and corticoidresistance in peripheral T cells from patients with multiple sclerosis. Immunology 2014; 143: 560-568.
65. Peelen E, Damoiseaux J, Smolders J, Knippenberg S, Menheere P, Tervaert JW et al. Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. J Neuroimmunol 2011; 240-241: 97-103.
66. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009; 132: 3329-3341.
67. Frisullo G, Nociti V, Iorio R, Patanella AK, Marti A, Caggiula M et al. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. Cytokine 2008; 44: 22-25.
68. Satoh J, Misawa T, Tabunoki H, Yamamura T. Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-kappaB as a biomarker for relapse of multiple sclerosis. Dis Markers 2008; 25: 27-35.
69. Bonetti B, Stegagno C, Cannella B, Rizzuto N, Moretto G, Raine CS. Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. Am J Pathol 1999; 155: 1433-1438.
70. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
71. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
72. de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 2008; 17: R122-R128.
73. Preuss C, Riemenschneider M, Wiedmann D, Stoll M. Evolutionary dynamics of co-segregating gene clusters associated with complex diseases. PLoS One 2012; 7: e36205.
74. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
75. Gerondakis S, Fulford TS, Messina NL, Grumont RJ. NF-kappaB control of T cell development. Nat Immunol 2014; 15: 15-25.
76. Brown J, Wang H, Hajishengallis GN, Martin M. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res 2011; 90: 417-427.
77. Wevers BA, Kaptein TM, Zijlstra-Willems EM, Theelen B, Boekhout T, Geijtenbeek TB et al. Fungal engagement of the C-type lectin mincle suppresses dectin-1-induced antifungal immunity. Cell Host Microbe 2014; 15: 494-505.
78. Hara H, Iizasa E, Nakaya M, Yoshida H. L-CBM signaling in lymphocyte development and function. J Blood Med 2010; 1: 93-104.
79. Pelzer C, Thome M. IKKα takes control of canonical NF-κB activation. Nat Immunol 2011; 12: 815-816.
80. Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng PH, Keats JJ, Wang H et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 2008; 9: 1364-1370.
81. Oh H, Ghosh S. NF-kappaB: roles and regulation in different CD4(+) T-cell subsets. Immunol Rev 2013; 252: 41-51.
82. Petrasch S. Follicular dendritic cells in malignant lymphomas. Curr Top Microbiol Immunol 1995; 201: 189-203.